ACM
PLSE icon

Aster Capital Management’s Pulse Biosciences PLSE Stock Holding History

Aster Capital Management’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Buy
105
+44
+72% +$812 ﹤0.01% 762
2025
Q4 		$838 Sell
61
-173
-74% -$2.7K ﹤0.01% 1008
2025
Q3 		$4.14K Sell
234
-261
-53% -$4.13K ﹤0.01% 821
2025
Q2 		$7.47K Sell
495
-410
-45% -$6.8K ﹤0.01% 824
2025
Q1 		$16.6K Buy
905
+880
+3,520% +$16.4K ﹤0.01% 1008
2024
Q4 		$435 Sell
25
-52
-68% -$917 ﹤0.01% 1040
2024
Q3 		$1.35K Buy
+77
New +$1.31K ﹤0.01% 995

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Aster Capital Management's PLSE Position: Q1 2026 in Review

Aster Capital Management increased its Pulse Biosciences (PLSE) stake by 72% in Q1 2026, buying an estimated $812 and bringing the position to 105 shares worth $1.69K. The position accounts for ﹤0.01% of the portfolio, ranked #762.

Aster Capital Management first reported a position in PLSE in Q3 2024 and has held it in 7 quarters since. The position peaked at $16.6K in Q1 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Aster Capital Management held 105 shares of Pulse Biosciences worth $1.69K as of Q1 2026.
  • Aster Capital Management bought 44 Pulse Biosciences shares in Q1 2026, an estimated $812.
  • Pulse Biosciences made up ﹤0.01% of Aster Capital Management's portfolio in Q1 2026, its #762 holding.
  • Aster Capital Management first reported a position in Pulse Biosciences in Q3 2024 and has held it in 7 quarters since.
  • Aster Capital Management's Pulse Biosciences position peaked at $16.6K in Q1 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Aster Capital Management's 13F filing for Q1 2026, filed 13 May 2026.